Skip to content
knowrare
HealthSignal
Your condition community

Living with Tyrosinase-positive oculocutaneous albinism

A genetic condition (oculocutaneous albinism type 2) with light skin and hair and reduced color in the eyes, causing vision problems.

Understanding Tyrosinase-positive oculocutaneous albinism

Tyrosinase-positive oculocutaneous albinism (type 2) is a genetic condition that affects the coloring of the skin, hair, and eyes.

People usually have very fair skin and white or light hair. The iris and the retina have less color. Vision problems are usual, such as reduced sharpness, quick eye movements (nystagmus), crossed eyes, and light sensitivity. Long sun exposure raises the risk of skin damage and skin cancers, including melanoma.

Signs & symptoms

Symptoms vary from person to person. GARD lists these among the most common:

  • Very fair skin and light hair
  • Reduced sharpness of vision
  • Quick, rhythmic eye movements (nystagmus)
  • Strong sensitivity to light (photophobia)
  • Light-colored irises
  • Freckling

Not everyone has every symptom. GARD's list comes from the Human Phenotype Ontology.

Diagnosis

  1. Talk with your doctor

    Share the symptoms you've noticed, when they started and your family health history. Notes and photos can help.

  2. See a specialist

    Specialists who may be involved include eye disease specialists, genetic specialists and skin, hair, and nail specialists.

  3. Consider genetic testing

    Changes in OCA2 are linked to this condition. Genetic testing and counseling can help confirm a diagnosis and explain what it means for your family.

Care & treatment

Care team
Eye disease specialists (ophthalmologists); Genetic specialists (geneticists); Skin, hair, and nail specialists (dermatologists)
Expert care
Ask about multidisciplinary care centers for rare conditions
Treatment
GARD doesn't list specific treatments for this condition. Your care team will tailor care to your symptoms.
Research
Clinical trials and observational studies may be options. See the research section below.

General information, not medical advice. Your care team makes the decisions.

Everyday life

Living with a rare condition is easier with support.

  • Connect with The National Organization of Albinism and Hypopigmentation (NOAH) and other patient organizations
  • Keep notes on symptoms, changes and questions for appointments
  • Ask about patient registries that help research
  • Look into financial aid and travel resources for care visits
Bring these questions to your next doctor visit
Can genetic testing of the OCA2 gene confirm this diagnosis?
How should we protect the skin from sun and check for skin cancer?
Which eye specialist should follow my vision?

Quick facts

Symptoms usually startNewborn and as an Infant
InheritanceAutosomal Recessive
GenesOCA2

This condition is caused by changes in the OCA2 gene. It is autosomal recessive, so a child inherits a changed copy of the gene from each parent.

GeneticSkinInherited Metabolic

Also known as: albinism ii; albinism, oculocutaneous, type ii; albinism, oculocutaneous, type ii, modifier of; albinoidism; oca2; oca2 - tyrosinase-positive oculocutaneous albinism

Patient organizations

Source: NIH GARD · Tyrosinase-positive oculocutaneous albinismGARD ID 4038 · GARD page updated September 2026 · Plain-language summary by Know Rare; editorial review pending. General information, not medical advice.

You are more than your diagnosis

Perspectives from people navigating life with Tyrosinase-positive oculocutaneous albinism.

Explore the Tyrosinase-positive oculocutaneous albinism blog

Explore research for Tyrosinase-positive oculocutaneous albinism

Explore actively recruiting Tyrosinase-positive oculocutaneous albinism studies with HealthSpark.

HealthSpark

Find actively recruiting studies for Tyrosinase-positive oculocutaneous albinism with HealthSpark. Share your city to explore research near you.

  • Recruiting studies from ClinicalTrials.gov
  • Share your city to look for research near you
  • Eligibility is confirmed by the study team

Powered by HealthSpark, our AI chat helper

I can help you find recruiting Tyrosinase-positive oculocutaneous albinism studies. Enter a ZIP code, address or city below and I'll look within 50 miles.

Powered by HealthSpark, our AI chat helper · Study information from ClinicalTrials.gov · Eligibility is confirmed by the study team.

Get Signals for Tyrosinase-positive oculocutaneous albinism

Stay in the loop with community stories and updates from medical researchers.

HealthStoryfor Tyrosinase-positive oculocutaneous albinism

Create a living journal that talks back

HealthStory evolves private journaling with a living AI journal that talks back and asks thoughtful questions, helping you capture your Tyrosinase-positive oculocutaneous albinism experiences more deeply and prepare for better conversations with your doctors and care team.

Start your journal

Your journal is private. Sharing your story publicly is a separate choice, made with Share your story above.